Back to search
FDAFDA · Food and drugs·Recall number D-1570-2014

Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg, 90 count bottles, Rx only, Manufactured by: Apotex Research Pvt. Ltd. Bangalore - 560 099, India NDC 60505-3759-9

Published September 24, 2014 · Recall initiated: August 21, 2014

Summary

FDA records drug Class III recall D-1570-2014, published September 24, 2014 and initiated August 21, 2014. Recalling firm: Apotex Corp.; Status: Terminated; Reported quantity: 1,494 bottles; Lot: Lot # KK6086, exp 03/2015, UPC 360505375998. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurity/Degradation Specification; high out of specification for CAD II degradant

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Corp.
Distributor
Nationwide
Lot
Lot # KK6086, exp 03/2015, UPC 360505375998.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg, 90 count bottles, Rx only, Manufactured by: Apotex Research Pvt. Ltd. Bangalore - 560 099, India NDC 60505-3759-9 recalled?

Yes. FDA published recall D-1570-2014 on September 24, 2014. Reported hazard: Failed Impurity/Degradation Specification; high out of specification for CAD II degradant

What should I do if I have this product?

Voluntary: Firm initiated · Letter